Figure 4.
Hazard ratios for the primary efficacy (top) and safety (bottom) outcomes plotted over the range of baseline age. Hazard ratio > 1 favors warfarin over DOAC, whereas a hazard ratio < 1 favors DOAC over warfarin.
Footnote: X-axis truncated to include 5th and 95th percentiles.